Skip to main content

Table 3 Patient characteristics

From: Patient values in patient-provider communication about participation in early phase clinical cancer trials: a qualitative analysis before and after implementation of an online value clarification tool intervention

Subject

Decided to participate

(yes/no)

Gender

Age

Primary tumour location

Oncologist

Duration of consultation (minutes)

Used OnVaCT before consultation

(yes/no)

Pre-intervention, usual care/before implementation of the OnVaCT

01

No

Female

59

Colorectal/anal

A

28

N/A

02

No

Male

66

Oesophageal/stomach

B

49

N/A

03

No

Male

69

Oesophageal/stomach

C

41

N/A

04

No

Female

62

Urinary tract

D

33

N/A

05

Yes

Female

75

Gynaecological

C

45

N/A

06

Yes

Male

66

Urinary tract

D

53

N/A

07

Yes

Male

58

Lung/mesothelioma

B

20

N/A

08

Yes

Male

72

Urinary tract

A

38

N/A

09

No

Female

50

Gynaecological

E

35

N/A

10

Yes

Male

54

Melanoma/skin

F

51

N/A

11

Yes

Female

39

Other

G

39

N/A

12

No

Male

53

Colorectal/anal

H

32

N/A

13

Yes

Male

61

Oesophageal/stomach

E

32

N/A

14

No

Female

53

Colorectal/anal

F

50

N/A

15

Yes

Male

78

Lung/mesothelioma

H

36

N/A

16

Yes

Male

72

Lung/mesothelioma

I

34

N/A

17

No

Male

72

Colorectal/anal

I

28

N/A

Post-intervention, after implementation of the OnVaCT

18

No

Male

58

Other

C

42

Yes

19

No

Female

69

Colorectal/anal

B

43

Yes

20

Yes

Female

62

Colorectal/anal

B

32

No

21

No

Male

76

Other

A

29

Yes

22

Yes

Male

51

Other

A

29

Yes

23

Yes

Male

62

Oesophageal/stomach

D

44

Yesa

24

Yes

Female

42

Gynaecological

C

45

Yes

25

No

Male

73

Urinary tract

D

45

Yesa

26

Yes

Female

60

Oesophageal/stomach

E

30

Yesa

27

No

Female

50

Colorectal/anal

H

30

Yesa

28

No

Male

74

Oesophageal/stomach

F

28

Yesa

29

No

Male

68

Urinary tract

G

41

Yesa

30

Yes

Female

36

Gynaecological

F

28

Nob

31

No

Male

65

Colorectal/anal

I

34

Yesa

32

Yes

Female

55

Colorectal/anal

I

50

Yes

  1. a These patients filled out questions about the OnVaCT for another part of the project, but whether they had actually used it was not explicitly mentioned during the consultation
  2. b This patient did not fill out questions about the OnVaCT for another part of the project, and whether she had actually used it was not explicitly mentioned during the consultation